Related Experiment Video
Updated: May 18, 2026
11:28
Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
Published on: April 28, 2015
Advances in Prussian blue nanoparticle-based anticancer platforms: synthesis, functionalization, and therapeutic
Chittathur Midhun Krishna1, Rupa Mazumder1, Rakhi Mishra2
1Department of Pharmaceutics, Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, India.
Nanomedicine (London, England)
|May 16, 2026
Summary
Prussian blue nanoparticles show promise as an anticancer agent due to their unique properties. Further research is needed to overcome challenges for clinical application.
Area of Science:
- Nanotechnology
- Materials Science
- Oncology
Background:
- Prussian blue nanoparticles (PB NPs) are metal-organic frameworks with demonstrated biological safety.
- PB NPs exhibit photothermal and imaging properties beneficial for cancer theranostics.
- These nanoparticles possess biocompatibility, immunomodulating effects, and enzyme-like activity.
Purpose of the Study:
- To provide a comprehensive overview of Prussian blue nanoparticles for cancer therapy.
- To discuss the synthesis methods and anticancer mechanisms of PB NPs.
- To highlight the therapeutic potential of PB NPs in oncology.
Main Methods:
- Literature review of research articles published within the last 6 years.
- Data sourced from PubMed and Google Scholar.
- Focus on studies investigating PB NPs against cancer.
Main Results:
- Prussian blue nanoparticles demonstrate significant potential as an anticancer agent.
- Ongoing research explores their application in cancer treatment.
- PB NPs exhibit promising theranostic capabilities.
Conclusions:
- Prussian blue nanoparticles are a strong candidate for anticancer therapies.
- Clinical translation is currently limited by the absence of approved clinical trials.
- Active research indicates a bright future for PB NPs in oncology.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...